Snus does cause cancer. Snus is harmless. I hear both regularly, and both fall short from my perspective. In between lies what research actually reveals. Because on the topic of Snus and cancer, there are studies with different results, methodological limitations, and open questions. The data situation is more extensive than many think, but also more contradictory.
Those who look closely don't arrive at a clear answer, but get a nuanced picture. That's exactly what I'm trying to break down here, without wanting to simplify or dramatize the topic.
Tobacco-containing Snus and Nicotine Pouches are not the same thing
Behind the term "Snus" often lie completely different products. Are we talking about classic Swedish Snus with tobacco? About tobacco-free Nicotine Pouches? The distinction is important, because depending on the product, ingredients and thus also the potential cancer risk vary considerably.
Classic Swedish Snus contains tobacco and thus tobacco-specific nitrosamines (TSNAs), which are classified as carcinogenic. Due to strict production standards, TSNA levels in Swedish Snus are significantly lower than in many other tobacco products worldwide, but they are not zero.
Tobacco-free nicotine pouches, on the other hand, contain no tobacco, only nicotine as well as carrier and flavoring substances. This makes a difference for risk assessment, even though long-term data is still largely lacking here.
What studies show so far
The most comprehensive analysis to date comes from Valen et al. from 2023, published in the International Journal of Cancer. 15 studies were evaluated, almost exclusively from Sweden, on cancer risks in various organs: oral cavity, esophagus, stomach, pancreas, intestines, lungs, lymphatic system and others. The result is not uniform.
Important: The study situation on Snus and cancer is nuanced. Individual risks are being investigated, but not every claim is scientifically clearly proven.
For esophagus, rectum and pancreas, individual studies report indications of an increased risk with consumption of tobacco-containing Snus. For lung cancer and stomach cancer, on the other hand, most analyses show no clear connections. The review itself expressly evaluates confidence in its own estimates as moderate to very low, mainly due to methodological limitations in the primary studies.
Oral cancer: What the data says
Snus and oral cancer is the topic discussed most frequently. The data situation is particularly interesting because newer large studies deviate from what older individual studies had suggested.
A pooled analysis from nine Swedish cohort studies with over 418,000 male participants, published in the journal Tobacco Control, found no significant connection between Snus consumption and oral cancer. The hazard ratio was 0.90, slightly below the level of non-consumers, but this was not statistically significant. Even among never-smokers, no increased risk was shown. A much older, smaller study from 2008, however, had described an increased incidence of oral cavity cancer in daily Snus users. The difference is partly explained by methodology, sample size, and the weaker control of confounders such as smoking status and alcohol at that time.
An important distinction that is often overlooked: Snus users frequently develop so-called "Snuff Dipper's Lesions," i.e., mucosal changes at the application site. These are not equivalent to cancer. Current data show no clearly increased cancer probability from such lesions with Swedish Snus, even though changes in the oral cavity should generally be observed. More about the effects of Snus on gums can be found in a separate post.
Pancreas and other investigated cancer types
Pancreatic cancer has received particularly much attention in Snus research because earlier studies delivered conspicuous findings. A prospective cohort study from Norway (Boffetta et al., 2005) found an increased relative risk for pancreatic cancer in Snus consumers. A study of Swedish construction workers from 2007 came to similar results.
| Cancer type | Older studies | Newer / larger studies |
|---|---|---|
| Oral cancer | Individual indications of increased risk | No significant association (pooled analysis, n=418,000) |
| Pancreatic cancer | Increased risk in individual cohorts | No significant connection (pooled analysis, n=424,000) |
| Rectal cancer | Limited data situation | Slightly increased risk with high consumption in one study |
| Esophageal cancer | Contradictory | No clear association in current reviews |
| Lung cancer | No connection | No connection |
The early findings on the pancreas were significantly relativized by a pooled analysis by Araghi et al. from 2017, published in the International Journal of Cancer. With data from 424,152 men from nine Swedish cohorts, the team found no significant connection between Snus consumption and pancreatic cancer risk after adjustment for smoking status. The authors concluded that combustion products in cigarette smoke are likely the decisive factor for cancer risk in smokers, and not nicotine or nitrosamines alone.
How reliable is this research?
This is a question I consider central. Almost all existing studies on Snus and cancer are observational studies. They can show connections, but cannot prove causality. Those who consume more Snus might also eat differently, drink more alcohol, or have a different lifestyle. This can never be completely controlled in such studies.
In many early studies, smoking as a confounder was inadequately considered. Those who use Snus and simultaneously smoke or have smoked before significantly distort the result. Newer studies therefore specifically limit their analyses to never-smokers, which makes the estimates more reliable, but simultaneously reduces sample sizes. Additionally, exposure measurement in most studies is based on a single self-report at study beginning. Whether someone still consumes just as much Snus ten or twenty years later remains unknown.
- Observational studies cannot prove causality, but only show statistical connections that may be explained by other factors.
- Confounding through smoking, alcohol and lifestyle has often been insufficiently corrected in older studies, which limits their validity.
- Newer pooled analyses with very large samples are methodologically more robust, but they also don't replace controlled long-term experiments.
- Cancer diseases often develop only after decades, which is why short observation periods can systematically underestimate the risk.
What is currently being researched on Nicotine Pouches
For tobacco-containing Swedish Snus, there is now a comparatively solid database, even though open questions remain. For tobacco-free Nicotine Pouches, this looks completely different: These products have only been on the market in their modern form for a few years, and long-term data is simply still missing.
A review with data through January 2024, published in the journal Nicotine & Tobacco Research, evaluated 62 studies on tobacco-free Nicotine Pouches. The conclusion: Their pollutant content is lower than that of cigarettes and tobacco-containing Snus. Some of the identified ingredients, including Methyl Eugenol and Benzophenone, are classified by the International Agency for Research on Cancer as possibly carcinogenic. However, the amounts found were significantly below those in cigarettes or Snus.
For context: The FDA (Food and Drug Administration) approved 20 ZYN products in 2024 after extensive review because they have a lower cancer risk compared to cigarettes and tobacco-containing smokeless tobacco. Whether this remains the case long-term cannot be seriously assessed without long-term data.
What can be said seriously today
Based on current research, some statements can be made cleanly, others cannot. Snus is not equivalent to cigarette smoke: The carcinogenic effect of combustion products is scientifically very well documented and lies significantly above what has been shown for Snus. However, this does not mean that Snus is risk-free.
Study note: Statements about Snus and cancer must be supported by serious sources and explained in context. Contradictions between studies must not be omitted.
For tobacco-containing Snus, there are indications of possible connections with individual cancer types, especially with very long-term and intensive consumption. These indications are not strong enough for a clear causal statement, but also not strong enough to ignore them. What happens in the body during consumption, I have broken down in more detail in the guide to the effect of Snus.
Summary: What research provides today
- Tobacco-containing Snus contains nitrosamines with carcinogenic potential, but their content is significantly below that in cigarettes and many other tobacco products.
- Large pooled analyses from Sweden find no significant association between Snus consumption and oral cancer and pancreatic cancer in never-smokers.
- Older individual studies partly provide contradictory findings, but are methodologically less robust than newer pooled analyses with large samples.
- Tobacco-free nicotine pouches have a lower pollutant profile than tobacco-containing Snus according to previous research, but reliable long-term data is still almost completely missing.
- None of the current research reports allows a blanket statement: neither "Snus causes cancer" nor "Snus is harmless" can be scientifically maintained.
